Table 2. Association of hematological parameters in COVID-19 positive ICU versus non-ICU and death versus recovered cases.
AEC, absolute eosinophil count; ALC, absolute lymphocyte count; AMC, absolute monocyte count; ANC, absolute neutrophil count; COVID-19, coronavirus disease 2019; ICU, intensive care unit; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio
| Variable | Category | ICU | Non-ICU | Test of significance (p-value) | Death | Recovered | Test of significance (p-value |
| ANC | Normal | 30 (24.4%) | 93 (75.6%) | <0.001 | 10 (8.1%) | 113 (91.9%) | <0.001 |
| Neutropenia | 0 (0%) | 5 (100%) | 1 (20.0%) | 4 (80.0%) | |||
| Neutrophilia | 67 (54%) | 57 (46%) | 35 (28.2%) | 89 (71.8%) | |||
| ALC | Normal | 46 (30.7%) | 104 (69.3%) | 0.071 | 18 (12.0%) | 132 (88%) | 0.004 |
| Lymphocytosis | 2 (33.3%) | 4 (66.7%) | 0 (0%) | 6 (100%) | |||
| Lymphopenia | 42 (53.2%) | 37 (46.8%) | 24 (30.4%) | 55 (69.6%) | |||
| Severe lymphopenia | 7 (41.2%) | 10 (58.8%) | 4 (23.5%) | 13 (76.5%) | |||
| AEC | Normal | 87 (43.5%) | 114 (56.5%) | 0.007 | 42 (20.9%) | 159 (79.1%) | 0.031 |
| Eosinophilia | 10 (19.6%) | 41 (80.4%) | 4 (7.8%) | 47 (92.2%) | |||
| AMC | Normal | 32 (40.5%) | 47 (59.5%) | 0.469 | 15 (19.0%) | 64 (81.0%) | 0.705 |
| Monocytosis | 2 (66.7%) | 1 (33.3%) | 0 (0%) | 3 (100.0%) | |||
| Monocytopenia | 63 (37.1%) | 107 (62.9%) | 31 (18.2%) | 139 (81.8%) | |||
| Platelet count | Normal | 128 (62.2%) | 78 (37.8%) | 0.938 | 38 (18.4%) | 168 (81.6%) | 0.780 |
| Thrombocytosis | 5 (50%) | 5 (50%) | 1 (10%) | 9 (90%) | |||
| Thrombocytopenia | 22 (61.1%) | 14 (38.9%) | 7 (19.4%) | 29 (80.6%) | |||
| D-dimer (226 cases) | Normal | 13 (21.7%) | 47 (78.3%) | <0.001 | 54 (90.0%) | 6 (10.0%) | 0.046 |
| Abnormal | 75 (45.2%) | 91 (54.8%) | 130 (78.3%) | 36 (21.7%) | |||
| Variable | Cut-off value | ICU | Non-ICU | Test of significance (p-value) | Death | Recovered | Test of significance (p-value) |
| NLR | <3.17 | 10 (14.7%) | 58 (85.3%) | <0.001 | 4 (5.9%) | 64 (94.1%) | 0.002 |
| >3.17 | 87 (47.3%) | 97 (52.7%) | 42 (22.8%) | 142 (77.2%) | |||
| PLR | <150 | 41 (28.5%) | 103 (71.5%) | 0.002 | 20 (13.9%) | 124 (86.1%) | 0.038 |
| >150 | 56 (51.9%) | 52 (48.1%) | 26 (24.1%) | 82 (75.9%) | |||
| Variable | Anemia | ICU | Non-ICU | Test of significance (p-value) | Death | Recovered | Test of significance (p-value) |
| Male | Anemic | 43 (37.7%) | 71 (62.3%) | 0.824 | 22 (19.3%) | 92 (80.7%) | 0.332 |
| Normal | 26 (39.4%) | 40 (60.6%) | 9 (13.6%) | 57 (86.4%) | |||
| Female | Anemic | 19 (33.9%) | 37 (66.1%) | 0.106 | 10 (17.9%) | 46 (82.1%) | 0.245 |
| Normal | 9 (56.2%) | 7 (43.8%) | 5 (31.2%) | 11 (68.8%) |